InvestSMART

ResMed Inc. (ASX:RMD)

ALERT: Price-sensitive ASX Announcement for RMD
Current share price for RMD : $27.550 -9.99 (-26.61%)+
Announcement
Release
2 Feb 2026 8:15AM
Price at Release
$37.540
Full Release
download
Summary
ResMed Inc.'s Form 10-Q for the quarter ended December 31, 2025, reveals significant financial data and operational updates. The company reported a net income of $392.6 million for the quarter, with a year-to-date net income of $741.1 million. Revenues from Sleep and Breathing Health products and Residential Care Software showed substantial growth, contributing to a total net revenue of $1.42 billion for the quarter. The document outlines ResMed's increased focus on research and development, with expenses in this area rising to $90.9 million in the quarter. The company's financial position remained robust, with total assets of $8.50 billion and equity of $6.32 billion. ResMed declared a dividend of $0.60 per share for the quarter, reflecting its commitment to returning value to shareholders. The report includes a detailed analysis of operating expenses, tax provisions, and other comprehensive income, emphasizing strategic investments and market risk management.
Key Points
  • Net income for the quarter was $392.6 million.
  • Total net revenue for the quarter was $1.42 billion.
  • Significant growth in Sleep and Breathing Health products and Residential Care Software.
  • Research and development expenses increased to $90.9 million.
  • Total assets were $8.50 billion with equity at $6.32 billion.
  • Declared a dividend of $0.60 per share.
  • Emphasis on strategic investments and market risk management.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.